Provided by Tiger Trade Technology Pte. Ltd.

Trevi Therapeutics, Inc.

15.90
-0.0100-0.06%
Post-market: 15.900.00000.00%19:30 EDT
Volume:2.02M
Turnover:32.43M
Market Cap:2.26B
PE:-45.20
High:16.57
Open:16.20
Low:15.87
Close:15.91
52wk High:20.22
52wk Low:7.65
Shares:142.00M
Float Shares:118.00M
Volume Ratio:1.69
T/O Rate:1.71%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3518
EPS(LYR):-0.3173
ROE:-19.66%
ROA:-13.82%
PB:7.02
PE(LYR):-50.11

Loading ...

Aug 07, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 06, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2026

Major Issues Report

Form 8-K - Current report
Aug 06, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jun 04, 2026

Major Issues Report

Form 8-K - Current report
May 06, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 05, 2026

Major Issues Report

Form 8-K - Current report
May 05, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 17, 2026

Major Issues Report

Form 8-K - Current report
Mar 17, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 17, 2026

Major Issues Report

Form 8-K - Current report
Mar 10, 2026

Major Issues Report

Form 8-K - Current report
Dec 05, 2025

Major Issues Report

Form 8-K - Current report
Nov 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2025

Major Issues Report

Form 8-K - Current report
Oct 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 20, 2025

Major Issues Report

Form 8-K - Current report
Aug 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]